Continuous vs Intermittent Ketorolac for Pediatric Heart Surgery
Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery
- Age
- 3 Months – 59 Months
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 166 (estimated)
- Sponsor
- Phoenix Children's Hospital · Other
This trial is looking for children aged 3 months to 4 years who have had heart surgery. Participants will receive either continuous or intermittent doses of ketorolac to manage pain after their procedure.
You may be able to join if
- I am between 3 months and 4 years old.
- I have had heart surgery and am in the CVICU.
- I can start ketorolac within 12-24 hours after my surgery.
- My doctor thinks ketorolac is the right pain relief for me.
You may not be able to join if
- I have acute kidney injury.
- I am allergic to ketorolac or any NSAID medications.
- I need mechanical support like ECMO within 48 hours after surgery.
- I have had a heart transplant.
- I have significant bleeding.
- I have known kidney problems before my surgery.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe proposed study will be a prospective, randomized, double blind, placebo controlled trial to compare the use of a continuous infusion versus intermittent ketorolac on postoperative patients in the pediatric cardiovascular ICU. We intend to determine if the continuous infusion leads to a decreased utilization of opiates when compared to intermittent ketorolac.
Loading trial locations…